Uncomplicated Diverticulitis: When Nothing Is the Evidence-Based Choice
Every criterion in the trials that changed this practice is met right here, in this patient, on this visit. Whether that’s enough to actually withhold a familiar prescription is the real test of an evidence-based policy.
Frank D., a 58-year-old accountant, came to the emergency department with two days of steady left lower quadrant pain, low-grade fever, and mild nausea, his first episode of anything like this in his life. A CT scan confirmed acute diverticulitis with localized inflammatory changes around a short segment of sigmoid colon — no abscess, no free air, no evidence of perforation or fistula — the textbook definition of uncomplicated disease. He is otherwise healthy, on no immunosuppressive medications, tolerating oral intake without difficulty, and his pain is manageable with over-the-counter analgesics; by every criterion the major trials on this exact question used to define their study population, he fits.
He lives with his wife, has reliable phone and transportation access, and has already expressed he would rather avoid an unnecessary medication if the evidence genuinely supports it — having read, before this visit, that some diverticulitis cases don’t require antibiotics at all, which surprised him given how routinely he’d assumed this diagnosis was treated. The team now has to decide whether to discharge him with a course of ciprofloxacin and metronidazole, the traditional approach, or manage this episode with observation and supportive care alone, informed by AVOD and DIABOLO, two separate randomized trials that found no meaningful difference in outcomes between the two approaches for patients who look exactly like him.
The mechanistic reasoning behind that finding, once counterintuitive to most clinicians trained before these trials, has become clearer with time: uncomplicated diverticulitis, unlike its complicated forms, is now understood to be driven substantially by localized inflammation rather than active bacterial invasion of tissue requiring systemic antimicrobial suppression to resolve — which is why bowel rest and time, not antibiotic coverage, do most of the actual clinical work in a patient whose imaging shows no abscess, no perforation, and no free air. That reasoning is tidier in retrospect than it was in advance, though — the mechanism was proposed largely to explain trial results that had already surprised everyone, and both AVOD and DIABOLO were designed to detect differences in recovery and complications, not to test why the antibiotics turned out not to matter. He fits the trials. Whether the explanation for the trials is correct is a separate question nobody at this visit needs to settle.
Emergency department, disposition planning
I’d manage this without antibiotics. Both AVOD and DIABOLO, two separate randomized trials, found no difference in recovery time, complication rate, or recurrence between antibiotics and observation for uncomplicated diverticulitis in immunocompetent patients — and current AGA guidance reflects that by endorsing selective, not routine, antibiotic use. He meets every criterion those trials used to define the population that gains nothing from antibiotics.
I don’t dispute the trial data at the population level — I want us to be careful about applying it reflexively on a first presentation, before he has any personal experience with how this usually goes. Departing from decades of standard antibiotic practice deserves the same careful confirmation of uncomplicated status — reliable follow-up, no worsening on exam, adequate pain control at home — that any real change in practice should get, not just citing the trial and moving on.
I think this converges cleanly once we make it explicit. Apply the guideline — he genuinely meets the criteria, confirmed today, not assumed — and build a real follow-up plan around it: a phone check-in at 48 hours, explicit return precautions for worsening pain or fever, and a clinic visit within a week. That turns "no antibiotics" into an actively monitored plan rather than simply sending him home with nothing.
Agreed: discharge home without antibiotics, with a scheduled 48-hour phone check-in, explicit written return precautions for fever, worsening pain, or inability to tolerate oral intake, and a follow-up clinic visit within one week.
His 48-hour check-in confirmed steady improvement, and his one-week follow-up visit showed near-complete symptom resolution; no antibiotics were ultimately needed for this episode.